Table 3.
Treatment (Tx) status (current and history) (N = 152).
Tx* | First-line Tx | Second-line Tx | Third-line Tx | Subsequent Tx |
---|---|---|---|---|
Current Tx at time of enrollment | ||||
Radiation alone | 2 (1.3) | 1 (0.7) | – | – |
Systemic Tx alone | 42 (27.6) | 26 (17.1) | 21 (13.8) | |
Radiation and systemic | 9 (5.9) | 1 (0.7) | – | – |
No current Tx† | – | – | – | – |
Tx received | ||||
Surgery | 3 (2.0) | 4 (2.6) | – | – |
Radiation | 6 (3.9) | 5 (3.3) | 1 (0.7) | – |
Systemic Tx | 87 (57.2) | 49 (32.2) | 23 (15.1) | 10 (6.6) |
Surgery + systemic Tx | 3 (2.0) | – | – | – |
Radiation + systemic Tx | 21 (13.8) | 2 (1.3) | 1 (0.7) | 1 (0.7) |
Surgery + radiation + systemic Tx | 3 (2.0) | – | – | – |
Not applicable | 29 (19.1) | 92 (60.5) | 127 (83.6) | – |
Those who received systemic Tx | ||||
Received a platinum-based regimen | 101 (66.4) | 16 (10.5) | 4 (2.6) | 2 (1.3) |
Received a targeted therapy | 35 (23.0) | 31 (20.4) | 13 (8.6) | 5 (3.3) |
Values are presented as n (%).
Fifty patients (32.9%) were not currently undergoing Tx.